期刊文献+

Livin异构体特异性shRNA对宫颈癌Hela细胞凋亡的影响 被引量:2

Apoptosis of cervical cancer cell line Hela induced by Livin isoform-specific shRNA
下载PDF
导出
摘要 目的:应用构建成功的Livin异构体(BIRC71,BIRC72)短发夹RNA(short hairpin HNA,shRNA)真核表达载体转染Hela细胞,探讨其对Livin基因的沉默效应及诱导Hela细胞凋亡的作用。方法:采用脂质体转染法转染Hela细胞,荧光实时定量PCR、Western blotting检测转染前后宫颈癌Hela细胞Livin基因拷贝数和蛋白表达的变化,将shRNA表达载体流式细胞术检测不同时间(24、48、72h)的细胞凋亡率。结果:真核表达载体的转染效率48 h较24、72 h高;转染pGenesil-1- BIRC71、pGenesil-1-BIRC72后Hela细胞中Livin拷贝数明显减少(P<0.05),蛋白质表达水平显著降低(P<0.05);流式细胞术检测24、48、72 h凋亡率,转染Livin shRNA组细胞的凋亡率显著高于对照组(P<0.05),随时间延长(24→72 h)凋亡率相应增加。结论:靶向Livin的shRNA真核表达载体可以有效特异地阻断Livin基因的表达。 Objective: To transfect a recombinant short hairpin RNA (shRNA) expression vector targeting Livin gene isoform ( B1RCT1, BIRC72 ) into the cervical cancer cell line ( Hela cell ), in an attempt to observe RNAi-mediated silencing on Livin gene and the induction of Hela apoptosis. Methods: Hela cells were transfected with the recombinant plasmid pGenesil-1-BIRC71, pGenesil-l-BIRC72 and pGenesil-1-HK via LipofectamineTM 2000. The expression levels of Livin was determined in Hela cells before and after transfection by fluorescence quantitative real-time PCR and Western blotting. The apoptosis rate of cells was determined by FCM 24,48 and 72 h after transfection. Results: The transfection efficiency at 48 h was higher than those at 24 and 72 h. After transfection with pGenesil-l-BIRC71 and pGenesil-l-BIRC72, gene and protein levels of Livin were significantly reduced ( P 〈 0.05 ). The apoptosis rate of Livin shRNA transfection group was significantly higher than that of the control group, and increased with the prolongation of time (24, 48, and 72 h ; P 〈0.05 ). Conclusion: pGenesil-1-B1RC71 and pGenesil-1-BIRC72 can effectively reduce Livin gene expression and induce apoptosis of Hela cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2008年第3期228-232,共5页 Chinese Journal of Cancer Biotherapy
基金 湖北省科技厅自然科学基金(No.4-306)~~
关键词 LIVIN基因 短发夹RNA 宫颈癌 凋亡 Livin gene short hairpin RNA (shRNA) cervical cancer apoptosis
  • 相关文献

参考文献16

  • 1Massad SL,Markwell S,Cejtin HE, et al. Risk of high- grade cervical intraepithelial neoplasia among young women with abnormal screening cytology[J]. J Low Genit Tract Dis, 2005,9(4) : 225- 229.
  • 2Nguyen T, Menocal EM, Harborth J, et al. RNAi therapeutics: an update on delivery[J]. Curr Opin Mol Ther, 2008, 10(2) : 158- 167.
  • 3Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas[J]. Curt Biol, 2000, 10(21 ) : 1359-1366.
  • 4Ashhab Y, Alian A , Polliack A , et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern [J]. FEBS Lett, 2001,495(1-2) : 56-60.
  • 5Yagihashi A, Asanuma K, Tsuji N, et al. Detection of anti-Livin antibody in gastrointestinal cancer patients [ J ]. Clin Chem, 2003, 49(7) : 1206-1208.
  • 6Gazzaniga P,Gradilone A,Giuliani L, et al. Expression and prognostic significance of Livin, Survivin and other apoptosis-related genes in the progression of superficial bladder cancer[J]. Ann Oncol, 2003, 14(1) : 85-90.
  • 7于利利,王泽华.凋亡抑制蛋白Livin shRNA真核表达载体的构建[J].华中科技大学学报(医学版),2007,36(4):489-491. 被引量:6
  • 8Varela-Ledo E, Romero-Yuste S, Ordonez-Barbosa P, et al. CMV DNA detection in plasma using real-time PCR based on the SYBR- Green Ⅰ dye method [J]. Enferm Infecc Microbial Clin,2006, 24 (9) : 541-545.
  • 9Zhang YC, Taylor MM, Samson WK, et al. Antisense inhibition: oligonucleotides ribozymes and siRNAs [ J ]. Methods Mol Med, 2005, 106: 11-34.
  • 10朱静,王应雄,张晓萍,王金菊,张小飞,田杰.Gcn5基因shRNA的载体构建及其对干细胞分化中组蛋白乙酰化修饰的干扰作用[J].中华医学遗传学杂志,2006,23(1):43-46. 被引量:5

二级参考文献4

共引文献9

同被引文献21

  • 1陈晓,杨春鹿,赵君,李大朋,张林.非小细胞肺癌组织Livin和Smac蛋白表达及其临床意义的研究[J].中华肿瘤防治杂志,2008,15(12):905-909. 被引量:24
  • 2袁云霞,徐文方,刘健,陈明慧,孟红,曲显俊.基质金属蛋白酶抑制剂LY52对人卵巢上皮癌细胞SKOV3中MMP-2,MMP-9表达及其侵袭转移能力的抑制作用[J].癌症,2006,25(6):663-670. 被引量:13
  • 3Nagira M, Imai T, Hieshima K, et al. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13[J]. J Biol Chem, 1997,272(31): 19518- 19524.
  • 4Henning G,Ohl L,Junt T,et al. CC chemoldne receptor 7-dependent and independent pathways for lymphocyte homing: modulation by FTY720[J]. J Exp Med,2001,194(12) :1875-1881.
  • 5Kakinuma T, Hwang ST. Chemokines, ehemokine receptors, and cancer metastasis[J]. J Leukoc Biol, 2006,79 (4) :639-651.
  • 6Wu S, Xing W,Peng J,et al. Tumor transfected with CCL21 enhanced reactivity and apoptosis resistance of human monocyte-de rived dendritic cells[J].Immunobiology,2008,213(5):417-426.
  • 7Malmberg KJ. Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? [J]. Cancer Immunol Immunother, 2004, 53 (10) : 879- 892.
  • 8Smolewski P, Robak T. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancie [J]. Curr Mol Med, 2011,11(8) :663-649.
  • 9Yan B. Research progress on Livin protein : an inhibitor of apopto- sis[ J]. Mol Cell Biochem, 2011,357 ( 1 ) :39-45.
  • 10Cmkovie MI, Hoppe SF, Butzl K. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the Iivin/ML-IAP/KIAP gene [J]. Oncogene, 2003,22(51 ) :8330-8336.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部